Journal
GLYCOBIOLOGY
Volume 11, Issue 12, Pages 129R-143RPublisher
OXFORD UNIV PRESS INC
DOI: 10.1093/glycob/11.12.129R
Keywords
congenital disorders of glycosylation; genetic disorder; LAD-II; mannose; N-linked oligosaccharide
Categories
Funding
- NIDDK NIH HHS [R01 DK 55615] Funding Source: Medline
- NIGMS NIH HHS [R01 GM 55695] Funding Source: Medline
Ask authors/readers for more resources
Defects in nine genes of the N-linked glycosylation pathway cause congenital disorders of glycosylation (CDGs) and serious medical consequences. Although glycobiology is seldom featured in a general medical education, an increasing number of physicians are becoming acquainted with the field because it directly impacts patient diagnosis and care. Medical practice and attitudes will change in the postgenomic era, and glycobiology has an opportunity to be a cornerstone of part of that new perspective. This review of recent developments in the CDG field describes the biochemical and molecular basis of these disorders, describes successful experimental approaches, and points out a few perspectives on current problems. The broad, multisystemic presentations of these patients emphasize that glycobiology is very much a general medical science, cutting across many traditional medical specialties. The glycobiology community is well poised to provide novel perspectives for the dedicated clinicians treating both well-known and emerging human diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available